New Xarelto Lawsuit Update: Florida Case Filed
Attorney Marc Goldich gives an update on the latest Xarelto lawsuit filed in Florida.
BloodThinnerHelp.com reports today on one of the latest lawsuits filed against the manufacturers of Xarelto. This lawsuit, filed by a widower from Florida, alleges that Xarelto was the cause of a severe internal bleeding event that led to the serious injury and death of her husband.
The lawsuit is filed against Xarelto’s manufacturers, Bayer AG and Janseen Pharmaceuticals, the pharmaceutical division of Johnson&Johnson. It was filed in the United States District Court for the Southern District of Florida on June 23, 2014 and is listed under the case number 9:14CV80831. You can read and download the full complaint here.
Details of Xarelto Wrongful Death Lawsuit
The lawsuit details that the plaintiff’s late husband was prescribed Xarelto by his primary care physician on January 10, 2012 to treat his atrial fibrillation and reduce the risk of deep vein thrombosis and blood clots. After he began to take the drug, the deceased suffered a subdural hemorrhage, or a bleed outside of the brain. He was hospitalized for several days where he underwent several procedures to try to stop the severe subdural bleeding. On June 28, 2012, the plaintiff’s husband died as a result of internal bleeding complications. The plaintiff alleges that Xarelto was the cause of the hemorrhage and that if her and her husband were made aware of the real risks associated with Xarelto usage, they would have chosen to use one of the safer alternatives that were on the market at the time.
Xarelto’s Dangerous Lack of Antidote
Xarelto is considered to be a more dangerous drug than other traditional blood thinners on the market, such as Warfarin, because Xarelto does not have a corresponding antidote. This means that there is no way to reverse the anticoagulant effects of the drug in an emergency so if a patient suffers from an internal bleeding event while taking Xarelto, the bleeding cannot be stopped. In contrast, if a patient is taking Warfarin and suffers from an internal bleeding event, a doctor simply has to administer vitamin K and the patient’s blood will clot again. In the case of the deceased, since there is no antidote to Xarelto, the bleeding could only be curbed through very extreme measures such as a bur hole in his skull and a transfusion of new blood to remove the drug from the system. Sadly, despite these extreme efforts, many deaths similar to the plaintiff’s husband have occurred.
The plaintiff in Florida is bringing forward a wrongful death lawsuit alleging that the manufacturers of Xarelto were aware of the serious risks around the drug and deliberately concealed this information from doctors and patients. A wrongful death lawsuit will give them the chance to recover compensation for medical bills, burial and funeral expenses, along with the loss of future income, support, and companionship.
Recently, many of the federally filed lawsuits against Xarelto have been consolidated into a multidistrict litigation, MDL, in the Eastern District of Louisiana. The MDL will enable cases to move quickly through the system and regardless of the consolidation, these are still cases brought individually by each plaintiff and settlements may be different for everyone if they are reached.
“If Xarelto’s manufacturers deliberately concealed information about the drug from the public, they deserve to be held responsible for their actions.” Xarelto attorney Marc Goldich said, “We strongly encourage anyone who feels that they may have been harmed by Xarelto to contact us immediately.”
For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.